News on Phenomix Corporation from BioPortfolio.com http://www.BioPortfolio.com Consolidated Phenomix Corporation news from BioPortfolio.com Wed, 10 Feb 2010 07:01:56 GMT en Forest Laboratories, Inc. Reports Fiscal Third Quarter 2010 Earnings Per Share of $0.69, Including One-Time Chhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3950182&HITNO=0&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3950182&THISHREF=http://c.moreover.com/click/here.pl%3fz2489510047%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3950182&HITNO=0&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3950182&THISHREF=http://c.moreover.com/click/here.pl%3fz2489510047%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmiWeb: Forest Laboratories, Inc. Reports Fiscal Third Quarter 2010 Earnings Per Share of $0.69, Including One-Time Chhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931334&HITNO=1&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931334&THISHREF=http://c.moreover.com/click/here.pl%3fz2480446781%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3931334&HITNO=1&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3931334&THISHREF=http://c.moreover.com/click/here.pl%3fz2480446781%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Forest Laboratories, Inc. Reports Fiscal Third Quarter 2010 Earnings Per Share of $0.69, Including One-Time Chhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3930082&HITNO=2&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3930082&THISHREF=http://c.moreover.com/click/here.pl%3fz2479887304%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3930082&HITNO=2&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3930082&THISHREF=http://c.moreover.com/click/here.pl%3fz2479887304%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Forest Laboratories, Inc. Reports Fiscal Third Quarter 2010 Earnings Per Share of $0.69, Including One-Time Chhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3929844&HITNO=3&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3929844&THISHREF=http://c.moreover.com/click/here.pl%3fz2479786004%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3929844&HITNO=3&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3929844&THISHREF=http://c.moreover.com/click/here.pl%3fz2479786004%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Forest Laboratories, Inc. Reports Fiscal Third Quarter 2010 Earnings Per Share of $0.69, Including One-Time Charges Totaling $0.28 Per Sharehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3929067&HITNO=4&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3929067&THISHREF=http://c.moreover.com/click/here.pl%3fz2479467695%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3929067&HITNO=4&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3929067&THISHREF=http://c.moreover.com/click/here.pl%3fz2479467695%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Forest Laboratories, Inc. Reports Fiscal Third Quarter 2010 Earnings Per Share of $0.69, Including One-Time Chhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3928881&HITNO=5&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3928881&THISHREF=http://c.moreover.com/click/here.pl%3fz2479375789%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3928881&HITNO=5&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3928881&THISHREF=http://c.moreover.com/click/here.pl%3fz2479375789%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: Forest Laboratories, Inc. Reports Fiscal Third Quarter 2010 Earnings Per Share of $0.69, Including One-Time Charges Totaling $0.28 Per Sharehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3928593&HITNO=6&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3928593&THISHREF=http://c.moreover.com/click/here.pl%3fz2479263721%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3928593&HITNO=6&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3928593&THISHREF=http://c.moreover.com/click/here.pl%3fz2479263721%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Dutogliptin shows preliminary efficacy in Type 2 diabeteshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897481&HITNO=7&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897481&THISHREF=http://c.moreover.com/click/here.pl%3fz2462255708%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3897481&HITNO=7&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3897481&THISHREF=http://c.moreover.com/click/here.pl%3fz2462255708%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedWire News: Startups Thrive On the Scraps Of Defunct Life Sciences Firmshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3890360&HITNO=8&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3890360&THISHREF=http://c.moreover.com/click/here.pl%3fz2459177496%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3890360&HITNO=8&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3890360&THISHREF=http://c.moreover.com/click/here.pl%3fz2459177496%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Diego Business Journal: Phenomix grants Italian firm European rights to diabetes drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3868633&HITNO=9&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3868633&THISHREF=http://c.moreover.com/click/here.pl%3fz2447745443%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3868633&HITNO=9&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3868633&THISHREF=http://c.moreover.com/click/here.pl%3fz2447745443%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Discovery News: Phenomix grants Chiesi Farmaceutici European rights to Dutogliptin for diabeteshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3742608&HITNO=10&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3742608&THISHREF=http://c.moreover.com/click/here.pl%3fz2383703912%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3742608&HITNO=10&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3742608&THISHREF=http://c.moreover.com/click/here.pl%3fz2383703912%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaBiz: Phenomix Grants Chiesi Farmaceutici European Rights to Dutogliptin for Diabeteshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3723945&HITNO=11&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3723945&THISHREF=http://c.moreover.com/click/here.pl%3fz2374084668%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3723945&HITNO=11&MSIZE=12&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Phenomix%20Corporation&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3723945&THISHREF=http://c.moreover.com/click/here.pl%3fz2374084668%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: